SCHEMBL25969107

SCHEMBL25969107

Cc1ccc(-c2ccc(=O)n(CC(N)=O)n2)cc1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.69
▸ ALDH1A1 P00352 5/20 0.69
▸ HSD17B10 Q99714 2/20 0.69
▸ SMN1; SMN2 Q16637 2/20 0.69
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ POLB P06746 2/20 0.60
▸ USP2 O75604 1/20 0.60
▸ MAPK1 P28482 1/20 0.60
▸ TP53 P04637 3/20 0.59
▸ CYP2D6 P10635 2/20 0.58
▸ MAPT P10636 1/20 0.58
▸ CYP1A2 P05177 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ TSHR P16473 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25969306 0.85 TSHR (0.66) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL26363706 0.85 HTT (0.64) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL29457946 0.85 LMNA (0.64) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL30297703 0.79 KDM4E (0.45) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL24029943 0.79 MKNK1 (0.49) KDM4EALDH1A1HSD17B10SMN1; SMN2POLB
SCHEMBL18169216 0.78 TP53 (0.65) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL23495112 0.78 MEN1 (0.68) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL23495111 0.78 MEN1 (0.68) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL11218973 0.77 PDE4A (0.58) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL23495174 0.76 KDM4E (0.63) KDM4EALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3877052-B1 PYRIDAZINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS INC (US) 2023-08-16 — — EP disclosed
Send feedback